Gain Therapeutics's total assets for Q1 2025 were $11.62M, a decrease of -4.12% from the previous quarter. GANX total liabilities were $5.84M for the fiscal quarter, a 22.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.